First Interstate Bank’s Bioverativ Inc. Common Stock BIVV Stock Holding History

First Interstate Bank’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-95	Closed	-$5K	–	728
2017 Q4	$5K	Sell	95 -4	-4%	-$219	﹤0.01%	653
2017 Q3	$6K	Sell	99 -93	-48%	-$5.45K	﹤0.01%	609
2017 Q2	$12K	Buy	+192	New	+$10.9K	﹤0.01%	531

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

First Interstate Bank's BIVV Position: Q1 2018 in Review

First Interstate Bank sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 95 shares — an estimated $5K sold.

First Interstate Bank first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $12K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

First Interstate Bank reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
First Interstate Bank sold 95 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $5K.
First Interstate Bank first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
First Interstate Bank's Bioverativ Inc. Common Stock position peaked at $12K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on First Interstate Bank's 13F filing for Q1 2018, filed 26 Apr 2018.